Brecht, Belgium

Karin J Nuyens

This inventor holds 2 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karin J Nuyens. Retrieved from https://idiyas.com/inventor/karin-j-nuyens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karin J Nuyens

Introduction

Karin J Nuyens is a prominent inventor based in Brecht, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral compounds. With a total of 2 patents to her name, her work has the potential to impact the treatment of HIV-1.

Latest Patents

One of her latest patents is focused on a method of treating HIV-1 with .alpha.-substituted benzenemethanamine. This invention is concerned with antiretroviral compounds that possess the formula ##STR1##. The patent also includes pharmaceutical compositions containing these compounds and processes for preparing them. Another patent involves .alpha.-substituted benzenemethanamine derivatives and their pharmaceutical use, showcasing her innovative approach to combating viral infections.

Career Highlights

Karin J Nuyens is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. Her work at Janssen has allowed her to focus on groundbreaking research and development in the field of HIV treatment.

Collaborations

Throughout her career, Karin has collaborated with notable colleagues, including Marcel A Janssen and Georges H Van Daele. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Karin J Nuyens is a remarkable inventor whose work in the pharmaceutical sector is paving the way for innovative treatments for HIV-1. Her contributions are vital in the ongoing fight against viral infections, and her patents reflect her dedication to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…